Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1077 to 1126 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6439.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7031.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.092\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7031.8\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1083\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec15b. [source:swissprot;acc:q9y2d4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6213.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6785.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09198\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1084\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6437.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7029.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate transporter (g-3-p transporter) (g-3-p permease). [source:swissprot;acc:p57057]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6520.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7119.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09187\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proline oxidase, mitochondrial precursor (ec 1.5.3.-) (proline dehydrogenase). [source:swissprot;acc:o43272]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1087\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junction plakoglobin (desmoplakin iii). [source:swissprot;acc:p14923]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5732.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6256.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09139\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tax interaction protein 1. [source:refseq;acc:nm\_014604]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine--pyruvate aminotransferase (ec 2.6.1.51) (spt) (alanine-- glyoxylate aminotransferase) (ec 2.6.1.44) (agt). [source:swissprot;acc:p21549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6390.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1090\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5651.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6164.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09086\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1091\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1092\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1093\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1094\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5356.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5842.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homolog of yeast maf1. [source:refseq;acc:nm\_032272]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 2. [source:refseq;acc:nm\_178865]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 1 (transmembrane protein sbbi99). [source:swissprot;acc:q13530]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed 1 protein like. [source:swissprot;acc:q9nrx5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
d-3-phosphoglycerate dehydrogenase (ec 1.1.1.95) (3-pgdh). [source:swissprot;acc:o43175]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5462.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5958.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-62 antigen (fragment). [source:sptrembl;acc:q9y590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5843.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09062\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5359.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09054\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptotagmin xii (sytxii). [source:swissprot;acc:q8iv01]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5460.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5954.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09049\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rrp5 protein homolog (programmed cell death protein 11). [source:swissprot;acc:q14690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4846.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5283.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab3a interacting protein (rabin3)-like 1. [source:refseq;acc:nm\_013401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6545.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7132.89\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08979\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph:adrenodoxin oxidoreductase, mitochondrial precursor (ec 1.18.1.2) (adrenodoxin reductase) (ar) (ferredoxin-nadp(+) reductase). [source:swissprot;acc:p22570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5947.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6481.56\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab3a interacting protein isoform alpha 1; rabin3; ssx2 interacting protein. [source:refseq;acc:nm\_022456]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6540.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7127.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08972\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-methyltetrahydrofolate--homocysteine methyltransferase (ec 2.1.1.13) (methionine synthase, vitamin-b12 dependent) (ms). [source:swissprot;acc:q99707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5795.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6314.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08957\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynactin complex 50 kda subunit (50 kda dynein-associated polypeptide) (dynamitin) (dctn-50) (dynactin 2). [source:swissprot;acc:q13561]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5915.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6443.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08932\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4338.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4725.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08929\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nadp], mitochondrial precursor (ec 1.1.1.42) (oxalosuccinate decarboxylase) (idh) (nadp+-specific icdh) (idp) (icd-m). [source:swissprot;acc:p48735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7937.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8646.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5857.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6380.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08927\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 2 (esg2). [source:swissprot;acc:q04725]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6288.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6846.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6287.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6845.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08879\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-6 subunit (karyopherin alpha-5 subunit). [source:swissprot;acc:o15131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5792.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6305.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08867\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/